| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |